This browser doesn't support Spotify Web Player. Switch browsers or download Spotify for your desktop.

The Readout Loud

By STAT

Podcast by STAT

  1. 1.
    Episode 143: #JPM21: Déjà vu in Alzheimer's research, and OWS's legacy01/14/2021
    29:59
  2. 2.
    Episode 142: Bob Nelsen on the pandemic's next phase, plus Biden's biopharma plans & a CES preview01/07/2021
    29:14
  3. 3.
    Episode 141: Moderna's vaccine milestone, Warp Speed's hurdles, and biotech in 202112/18/2020
    34:55
  4. 4.
    Episode 140: Pfizer's Covid-19 vaccine — the debate, details, and distribution12/11/2020
    33:49
  5. 5.
    Episode 139: Angela Rasmussen on AstraZeneca's confusing data, & Adam Koppel on biotech in 202112/03/2020
    28:38
  6. 6.
    Episode 138: The latest Covid-19 vaccine, Biden's pandemic plans, and Bill Gates unfiltered11/19/2020
    23:07
  7. 7.
    Episode 137: Natalie Dean on Pfizer's Covid-19 vaccine, plus the FDA's Alzheimer's quandary11/12/2020
    29:23
  8. 8.
    Bracing for a pandemic winter, Biogen's fortune at the FDA, and remembering a remarkable 12-year-old11/05/2020
    30:37
  1. 9.
    Episode 135: Pfizer's Covid-19 mystery, Ashish Jha on pandemic response, & STAT turns 510/29/2020
    29:52
  2. 10.
    Episode 134: Erik Gordon on SPACs, plus Covid-19 vaccines, & Biogen's case in Alzheimer's10/22/2020
    24:59
  3. 11.
    Episode 133: A week of pauses, pharma’s statehouse spending, & how HBCUs approach Covid-19 trials10/15/2020
    28:06
  4. 12.
    Episode 132: How Trump's case of Covid-19 affects biotech, medicine, and the FDA with George Scangos10/08/2020
    23:07
  5. 13.
    Episode 131: Saad Omer on Covid-19 vaccine trials, & Ethan Weiss on intermittent fasting10/01/2020
    25:06
  6. 14.
    Episode 130: A road map for Covid-19, the gold rush in health tech, & D.C.'s pandemic unrest09/24/2020
    25:46
  7. 15.
    Episode 129: Heidi Tworek on pandemic PR, plus the CDC's credibility crisis & a lightning round09/17/2020
    26:25
  8. 16.
    Episode 128: AstraZeneca’s Covid-19 vaccine, coronavirus politics, & STAT’s Health Tech Summit09/10/2020
    25:03
  9. 17.
    Episode 127: Eric Topol on Stephen Hahn, plus Covid-19 vaccine timelines, & the 2000th First Opinion09/03/2020
    24:31
  10. 18.
    Episode 126: The FDA's chaotic week, Trump's effect on science, and Musk's big reveal08/27/2020
    24:38
  11. 19.
    Episode 125: Shocking FDA rejections, a longevity science setback & Derek Lowe on Covid-19 vaccines08/20/2020
    19:25
  12. 20.
    Episode 124: Pharma's lobbying dollars, Alnylam's future, and diversity in Covid-19 studies08/13/2020
    26:48
  13. 21.
    Episode 123: Steven Salzberg's Twitter debate, a health tech mega-deal & Covid-19 vaccine prices08/06/2020
    24:49
  14. 22.
    Episode 122: Gary Washburn on the NBA bubble, plus a DIY coronavirus vaccine, & behind VC numbers07/30/2020
    25:36
  15. 23.
    Episode 121: Kate Bingham on vaccine data, Meg Tirrell on covering Covid-19, & a DNA detective story07/23/2020
    25:15
  16. 24.
    Episode 120: Moderna's vaccine data, saving the U.S. pandemic response & systemic racism in medicine07/16/2020
    25:57
  17. 25.
    Episode 119: Trump's FDA pressure, a microcosm of the pandemic, and squabbling over a vaccine07/09/2020
    25:51
  18. 26.
    Episode 118: Remdesivir’s controversial cost, early vaccine promise, and AI at the end of life07/02/2020
    22:25
  19. 27.
    Episode 117: Covid-19’s U.S. surge, GSK’s mystery whistleblower, and cancer care under coronavirus06/25/2020
    22:48
  20. 28.
    Episode 116: Ezekiel Emanuel on vaccine politics & Tshaka Cunningham on diversifying genetic testing06/18/2020
    26:25
  21. 29.
    Episode 115: The Chan-Zuck uprising, a virtual BIO, and the struggle to treat Covid-1906/11/2020
    21:02
  22. 30.
    Episode 114: The killing of George Floyd, the drug industry's response, and what comes next06/04/2020
    22:40
  23. 31.
    Episode 113: Life after a coronavirus vaccine, virtual ASCO, and remembering Larry Kramer05/28/2020
    26:56
  24. 32.
    Episode 112: Moderna's scant coronavirus data and the plight of the day trader05/21/2020
    19:24
  25. 33.
    Episode 111: Covid-19 in the White House, a Parkinson’s experiment & public health lessons from porn05/14/2020
    26:59
  26. 34.
    Episode 110: Pandemic projections, Gilead's pricing dilemma & fighting Covid-19 in New York05/07/2020
    27:00
  27. 35.
    Episode 109: Scott Gottlieb on Covid-19 treatments, reopening America, and going on TV every day04/30/2020
    25:23
  28. 36.
    Episode 108: A vaccine official is ousted, how to use ventilators, & the fate of the JPM conference04/23/2020
    29:03
  29. 37.
    Episode 107: Covid-19 disrupts D.C., how not to be boring on Zoom, and the trial of Elizabeth Holmes04/16/2020
    27:19
  30. 38.
    Episode 106: Privacy in a pandemic, biopharma's big opportunity, and Shkreli's plea for a break04/09/2020
    24:55
  31. 39.
    Episode 105: Pandemic exit strategies, how the outbreak affects patients, and Ken Burns takes on DNA04/02/2020
    23:59
  32. 40.
    Episode 104: Fauci's star turn, the latest on coronavirus, and an under-the-radar Alzheimer's drug03/26/2020
    28:05
  33. 41.
    Episode 103: Trump's coronavirus pivot, life inside the ICU & drug development in a pandemic03/19/2020
    25:26
  34. 42.
    Episode 102: Voices from the coronavirus pandemic, in Italy, New York, and the high seas03/12/2020
    25:07
  35. 43.
    Episode 101: Pharma’s response to coronavirus, Google's appetite for health data, & biotech in China03/05/2020
    28:29
  36. 44.
    Episode 100: Wall Street's coronavirus freakout, clinical trial difficulties, and a look back02/27/2020
    28:47
  37. 45.
    Episode 99: Genetic medicine w/ Ethan Weiss, drug industry infighting, & a microbiome review02/20/2020
    29:56
  38. 46.
    Episode 98: Les Funtleyder on biotech investing; the Zolgensma lottery & billionaire philanthropy02/13/2020
    24:49
  39. 47.
    Episode 97: Fake outbreak news, treating coronavirus, and biotech's Mount Rushmore02/06/2020
    23:30
  40. 48.
    Episode 96: A chemist breaks bad, the latest on the coronavirus, and pharma’s slow Bern01/30/2020
    26:19
  41. 49.
    Episode 95: The latest on the China virus, Sarepta's ongoing FDA saga, and biotech at Davos01/23/2020
    22:02
  42. 50.
    Episode 94: EQRx's Alexis Borisy, Stephen Buck on his website for cancer patients, and a JPM recap01/16/2020
    23:15
  43. 51.
    Episode 93: Josiah Zayner on getting canceled, good news in cancer, an Ebola vaccine saga01/09/2020
    26:29
  44. 52.
    Episode 92: The decade in breakthroughs, the year in bad CEOs, and the viruses that cure disease12/19/2019
    24:51
  45. 53.
    Episode 91: CAR-T's future, an alarming cancer trend & Chris Garabedian on Sarepta's FDA legacy12/12/2019
    25:29
  46. 54.
    Episode 90: Biogen's big reveal, hot takes on Alzheimer's, & the science of one-eyed sheep12/05/2019
    24:46
  47. 55.
    Episode 89: Warren's awkward home front, a dwarfism drug, and the sound of STAT Summit11/22/2019
    24:56
  48. 56.
    Episode 88: Dr. David Sable on an alarming genetic test & Jorge Conde on the perils of bio-Twitter11/14/2019
    26:00
  49. 57.
    Episode 87: Derek Lowe on China's new Alzheimer's drug, blockbuster fish oil, & STAT's birthday11/07/2019
    20:06
  50. 58.
    Episode 86: Drugs that don't work, wearables in the desert, & excess 'innovation'10/31/2019
    28:18
  51. 59.
    Episode 85: Every angle on Biogen's shocking Alzheimer's news10/24/2019
    28:18
  52. 60.
    Episode 84: CRISPR with Netflix filmmakers, Pharma's future in China & where VC dollars come from10/17/2019
    26:13
  53. 61.
    Episode 83: How biotech VC works w/ health care journalist Maggie Fox, Vioxx and synthetic biology10/10/2019
    23:46
  54. 62.
    Episode 82: Drug shortages with Dr. Ben Davies, congressional paralysis & biotech's foul mood10/03/2019
    23:17
  55. 63.
    Episode 81: Vaping upheaval, DNA test dynamics, & the future of genome editing09/26/2019
    26:01
  56. 64.
    Episode 80: Unicorn growth spurts, Amgen's future, & mice on Twitter09/19/2019
    29:07
  57. 65.
    Episode 79: Pelosi's drug pricing plan, Moderna's mRNA drug factories, and a DIY disease cure09/12/2019
    19:36
  58. 66.
    Episode 78: Pharma existentialism, mainstreaming cyborgs, & FDA palace intrigue09/05/2019
    24:26
  59. 67.
    Episode 77: Purdue, J&J, and a week of big opioid crisis news08/29/2019
    18:17
  60. 68.
    Episode 76: Sarepta keeps a secret, an online army mobilizes, & China embraces biotech08/22/2019
    23:20
  61. 69.
    Episode 75: The serious side of spit kits, how BiTEs leave a mark, & Sarepta's sluggish study08/15/2019
    29:38
  62. 70.
    Episode 74: Novartis and the no good, very bad week08/08/2019
    19:33
  63. 71.
    Episode 73: Canadian pills, corporate jets, & racists with spit kits08/01/2019
    23:51
  64. 72.
    Episode 72: Vertex's regime change, the return of Ebola, & the rise of digital health07/25/2019
    26:33
  65. 73.
    Episode 71: Elon Musk's monkey cyborg, Gilead's shifting future, & an app for anxiety07/18/2019
    25:37
  66. 74.
    Episode 70: A whirlwind week in Washington, Sean Parker's mansion, & remembering a voice in biotech07/11/2019
    29:51
  67. 75.
    Episode 69: The future of AbbVieGan, the dogma of amyloid, & some questionable biotech marketing06/27/2019
    25:31
  68. 76.
    Episode 68: A controversial desire drug, courtroom genealogy, & the quest for longer life06/20/2019
    26:48
  69. 77.
    Episode 67: Biohacking meets bureaucracy, and the latest twist in CRISPR world06/13/2019
    25:03
  70. 78.
    Episode 66: The future of cancer treatment, blockbusters interrupted, & an infamous biotech party06/06/2019
    26:53
  71. 79.
    Episode 65: A special episode from the halls of the ASCO meeting06/04/2019
    29:30
  72. 80.
    Episode 64: Feuding professors, failing businesses, and journalism 10105/30/2019
    23:59
  73. 81.
    Episode 63: Your ASCO preview, genetic whiplash, and a journalist's experience with cancer05/23/2019
    31:33
  74. 82.
    Episode 62: Drug pricing partisanship, tech's march into health care, and Tinder for clinical trials05/16/2019
    23:24
  75. 83.
    Episode 61: Pharma felonies, cardiac CRISPR, and a strange day at the FDA05/09/2019
    25:03
  76. 84.
    Episode 60: Boardroom drama, whiskey-fueled science, & millionaires on mushrooms05/02/2019
    22:20
  77. 85.
    Episode 59: When scientists get mad online, for-profit cancer care, & the perils of naming a startup04/25/2019
    22:17
  78. 86.
    Episode 58: Democratizing CRISPR, drugging the undruggable, and reading pharma's fine print04/18/2019
    21:34
  79. 87.
    Episode 57: Trump’s drug pricing foot soldier, Gilead’s uncertain future, & transpacific angst04/11/2019
    25:21
  80. 88.
    Episode 56: Cheaper insulin, the next Juul, and diagnosing disease with sound04/04/2019
    28:51
  81. 89.
    Episode 55: The fate of Bristol-Myers-Celgene, the tragedy of SIDS, and health tech's challenges03/28/2019
    26:32
  82. 90.
    Episode 54: Another big Alzheimer’s failure, postpartum progress, and Long Island shores03/21/2019
    31:04
  83. 91.
    Episode 53: How startups stop, the new FDA boss, and Theranos on the big screen03/14/2019
    31:45
  84. 92.
    Episode 52: Every conceivable angle of Scott Gottlieb's FDA resignation03/07/2019
    28:28
  85. 93.
    Episode 51: CEOs at the Senate, merger mania, and sleuthing startups02/28/2019
    26:26
  86. 94.
    Episode 50: A big scoop on opioid marketing02/22/2019
    13:10
  87. 95.
    Episode 49: Painkiller racketeering, the limits of genetic tests, and pharma's day on the Hill02/21/2019
    23:54
  88. 96.
    Episode 48: The AI hype machine, ketamine's future, and the rocky path ahead for NASH02/14/2019
    23:46
  89. 97.
    Episode 47: A bad day for bold biotech, campaign 2020, and where do drugs come from?02/07/2019
    26:27
  90. 98.
    Episode 46: Another Alzheimer's setback, crypto for biotech, and a blessing of unicorns01/31/2019
    24:34
  91. 99.
    Episode 45: CRISPR upheaval, Celgene's chutzpah, and canine genomics01/24/2019
    24:54
  92. 100.
    Episode 44: FDA furloughs, '80s pop radio, and video game therapeutics01/17/2019
    23:55
  93. 101.
    Episode 43: A people's history of J.P. Morgan01/10/2019
    14:45
  94. 102.
    Episode 42: Parsing Bristol-Myers-Celgene, grousing about JPM, and how to not be boring01/03/2019
    22:04
  95. 103.
    Episode 41: Watson's latest stumble, a glimpse into the crystal ball, and revisiting Sarepta12/20/2018
    26:38
  96. 104.
    Episode 40: Gilead’s new boss, the year that was, and the thing about DNA tests12/13/2018
    23:16
  97. 105.
    Episode 39: Using the word 'cure,' an FDA loophole, & making biotech history12/06/2018
    22:44
  98. 106.
    Episode 38: Your guide to the #CRISPRbabies controversy11/29/2018
    23:56
  99. 107.
    Episode 37: The biggest-ever IPO, drug prices rising in tandem, and burner Twitter accounts11/15/2018
    26:17
  100. 108.
    Episode 36: What the midterms mean, a golden age on hold, and the $4 million drug11/08/2018
    22:46
  101. 109.
    Episode 35: Biotech's October slump, the precise cost of precision, and breaking postpartum silence11/01/2018
    26:12
  102. 110.
    Episode 34: Pharma at the ballot box, the latest Alzheimer's argument, and a rare disease dilemma10/25/2018
    21:35
  103. 111.
    Episode 33: Drug prices on TV, immortal blockbusters, and genetic privacy10/18/2018
    24:33
  104. 112.
    Episode 32: Fake friends at the FDA, cancer counter-narratives, and biotech's bear turn10/11/2018
    22:47
  105. 113.
    Episode 31: Nobel snubs, millenial founders, and a new kind of lightning round10/04/2018
    23:42
  106. 114.
    Episode 30: A fish oil epiphany, VC monopolies and ketamine clinics09/27/2018
    25:13
  107. 115.
    Episode 29: A Hong Kong heat-check, a $20 million wrist slap, and pharma's (other) diversity problem09/20/2018
    24:38
  108. 116.
    Episode 28: Founders' funds, doctors' disclosures, and the subtle art of beeping09/13/2018
    22:57
  109. 117.
    Episode 27: Live from Boston!09/06/2018
    26:08
  110. 118.
    Episode 26: FDA shows its teeth, biotech fish oil might be pointless, & treating McCain's cancer08/30/2018
    17:56
  111. 119.
    Episode 25: A genome-editing first, Trump on Wall Street, and biotech red flags08/23/2018
    21:48
  112. 120.
    Episode 24: A lesson in startup jargon, pharma's bare Alzheimer's cupboard, and the cost of CAR-T08/16/2018
    23:52
  113. 121.
    Episode 23: Congressional insider trading, PETA and fake meat, & doctors vs. fund managers08/09/2018
    21:09
  114. 122.
    Episode 22: Biotech's battle for talent, Sanofi's second act, and climbing Mt. Everest08/02/2018
    23:02
  115. 123.
    Episode 21 - A debatable Alzheimer's breakthrough, Gilead's golden age, and "robust" data07/26/2018
    24:58
  116. 124.
    Episode 20 - CRISPR freakouts, drug prices meet elections, and a busy earnings season07/19/2018
    25:30
  117. 125.
    Episode 19: Trump's telephonic prowess, Biogen's mysterious future, & the rise of 'hypelines'07/12/2018
    24:45
  118. 126.
    Episode 18: Biotech's six-month review, how to become a day trader and soul-searching analysts07/05/2018
    19:49
  119. 127.
    Episode 17: A friendly FDA, biosimilar awkwardness and how to sell drugs in China06/28/2018
    23:11
  120. 128.
    Episode 16: Sarepta's big week, Theranos' legal woes and parsing AI hype06/21/2018
    25:45
  121. 129.
    Episode 15: Problematic parties, Nitpicking NASH, and an opioid documentary from STAT06/14/2018
    23:45
  122. 130.
    Episode 14: Twitter vitriol, biotech jargon, and the plight of the CEO06/07/2018
    26:56
  123. 131.
    Episode 13: Spending millions on fatty liver disease. Overhyped cancer drugs. Who goes to BIO?05/31/2018
    22:31
  124. 132.
    Episode 12: Ebola should worry you, again; 23andMe's World Cup whoops; Don't drink sunscreen05/24/2018
    27:48
  125. 133.
    Episode 11: Inside the Theranos collapse, Valeant's latest legal lumps, and a few biotech hot takes05/17/2018
    22:45
  126. 134.
    Episode #10: Cohen, Trump, Novartis, oh my; Spark + Amish; Genetic testing at your doc's office?05/10/2018
    22:28
  127. 135.
    Episode #9 - Bill Gates on deadly flu, Chinese biotech bubbles, Golden State killer genetics05/03/2018
    27:36
  128. 136.
    Episode #8 - Megamergers, migraines, and biotech's Four Horsemen04/26/2018
    25:04
  129. 137.
    Episode #7 - Coke and Pepsi of lung cancer, a debatable drug price, and a cure for capitalism04/19/2018
    21:55
  130. 138.
    Episode #6 - Biotech buyouts, CEO breakups, and The Rock does CRISPR04/12/2018
    23:33
  131. 139.
    Episode #5 - The FDA's cold shoulder, the latest CAR-T contender, and BuzzFeed's scoop on Grindr04/05/2018
    22:32
  132. 140.
    Episode #4 - Mr. Drug CEO doesn't go to DC, billionaires fighting drug prices, a biotech report card03/29/2018
    23:36
  133. 141.
    Episode #3 - A gene therapy story, breaking down Incyte’s future, and was Gottlieb wrong to try?03/22/2018
    24:46
  134. 142.
    Episode #2 - Theranos’s fate, biotech’s awkward SXSW, and a word on cow loogies03/15/2018
    21:41
  135. 143.
    Episode #1 - Shkreli's sentence, biotech froth, and a blood party03/08/2018
    18:23
  136. 144.
    Coming soon: "The Readout LOUD"03/02/2018
    1:15

Listen to The Readout Loud now.

Listen to The Readout Loud in full in the Spotify app